• English Services 01

    Achieving and Maintaining Regulatory Compliance is our speciality.

  • English Services 02

    Tailored Solutions
    for your Regulatory
    Needs.

Medical devices must be designed and manufactured, ensuring compatibility between the device materials or substances which come in contact with the body and body tissues, taking into account the type, duration and frequency of the contact.

When seeking CE marking for a medical device which is intended to contact the body, the legal manufacturer must demonstrate that the device is biocompatible, for the specific application. The Biological Safety Assessment Report is the document required to demonstrate the device biocompatibility, regardless of its classification.

Part I of ISO 10993 (ISO 10993-1) provides a framework, a systematic approach to plan a biological evaluation (evaluation and testing) within a risk management process. Briefly, the systematic biological evaluation of medical devices involves the determination of the nature of body contact, the precise identification of the materials used in the device and the materials used during the manufacturing of the device, an assessment of the impact of the manufacturing process on the device biological safety characteristics, the evaluation of the existing clinically relevant (biocompatibility) data of these materials and as deemed necessary, if the data is non-existent or insufficient, the biocompatibility testing of the device. In certain cases, it may be possible to use data related to equivalent devices already on the market to establish a device biocompatibility if the equivalence has been demonstrated via chemical characterization (see ISO 10993-18).

Following the standard (ISO 10993-1) and guidance document (ISO/TR 15499) BioTop Medical supports the legal manufacturer of the device with the planning of the device biological safety assessment and the writing of an objective and compliant report.